% alzhub.org library filter % Source: https://alzhub.org/research?author=Scheltens+P&institution=I34352273 % 11 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{jansen2015-25988462, author = {Jansen, W. J. and Ossenkoppele, R. and Knol, D. L. and Tijms, B. M. and Scheltens, P. and Verhey, F. R. and Visser, P. J. and {Amyloid Biomarker Study Group} and others}, title = {{Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis}}, journal = {JAMA}, year = {2015}, doi = {10.1001/jama.2015.4668}, pmid = {25988462}, url = {https://doi.org/10.1001/jama.2015.4668} } @article{ossenkoppele2015-25988463, author = {Ossenkoppele, R. and Jansen, W. J. and Rabinovici, G. D. and Knol, D. L. and van der Flier, W. M. and van Berckel, B. N. and Scheltens, P. and Visser, P. J. and others}, title = {{Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis}}, journal = {JAMA}, year = {2015}, doi = {10.1001/jama.2015.4669}, pmid = {25988463}, url = {https://doi.org/10.1001/jama.2015.4669} } @article{visser2009-19523877, author = {Visser, P. J. and Verhey, F. and Knol, D. L. and Scheltens, P. and Wahlund, L. O. and Freund-Levi, Y. and Tsolaki, M. and Minthon, L. and others}, title = {{Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study}}, journal = {The Lancet. Neurology}, year = {2009}, doi = {10.1016/s1474-4422(09)70139-5}, pmid = {19523877}, url = {https://doi.org/10.1016/s1474-4422(09)70139-5} } @article{vanmaurik2019-31526625, author = {van Maurik, I. S. and Vos, S. J. and Bos, I. and Bouwman, F. H. and Teunissen, C. E. and Scheltens, P. and Barkhof, F. and Frolich, L. and others}, title = {{Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study}}, journal = {The Lancet. Neurology}, year = {2019}, doi = {10.1016/s1474-4422(19)30283-2}, pmid = {31526625}, url = {https://doi.org/10.1016/s1474-4422(19)30283-2} } @article{vanharten2013-24049134, author = {van Harten, A. C. and Smits, L. L. and Teunissen, C. E. and Visser, P. J. and Koene, T. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.}, title = {{Preclinical AD predicts decline in memory and executive functions in subjective complaints}}, journal = {Neurology}, year = {2013}, doi = {10.1212/wnl.0b013e3182a8418b}, pmid = {24049134}, url = {https://doi.org/10.1212/wnl.0b013e3182a8418b} } @article{jutten2021-34550903, author = {Jutten, R. J. and Sikkes, S. A. M. and Van der Flier, W. M. and Scheltens, P. and Visser, P. J. and Tijms, B. M. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity}}, journal = {Neurology}, year = {2021}, doi = {10.1212/wnl.0000000000012022}, pmid = {34550903}, url = {https://doi.org/10.1212/wnl.0000000000012022} } @article{korf2004-15249617, author = {Korf, E. S. and Wahlund, L. O. and Visser, P. J. and Scheltens, P.}, title = {{Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment}}, journal = {Neurology}, year = {2004}, doi = {10.1212/01.wnl.0000133114.92694.93}, pmid = {15249617}, url = {https://doi.org/10.1212/01.wnl.0000133114.92694.93} } @article{ramakers2013-22954311, author = {Ramakers, I. H. and Verhey, F. R. and Scheltens, P. and Hampel, H. and Soininen, H. and Aalten, P. and Rikkert, M. O. and Verbeek, M. M. and others}, title = {{Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment}}, journal = {Psychological medicine}, year = {2013}, doi = {10.1017/s0033291712001870}, pmid = {22954311}, url = {https://doi.org/10.1017/s0033291712001870} } @article{vanharten2013-23232269, author = {van Harten, A. C. and Visser, P. J. and Pijnenburg, Y. A. and Teunissen, C. E. and Blankenstein, M. A. and Scheltens, P. and van der Flier, W. M.}, title = {{Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2013}, doi = {10.1016/j.jalz.2012.08.004}, pmid = {23232269}, url = {https://doi.org/10.1016/j.jalz.2012.08.004} } @article{vermunt2019-31068481, author = {Vermunt, L. and van Paasen, A. J. L. and Teunissen, C. E. and Scheltens, P. and Visser, P. J. and Tijms, B. M. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal}}, journal = {Neurology}, year = {2019}, doi = {10.1212/wnl.0000000000007609}, pmid = {31068481}, url = {https://doi.org/10.1212/wnl.0000000000007609} } @article{visser1999-10431775, author = {Visser, P. J. and Scheltens, P. and Verhey, F. R. and Schmand, B. and Launer, L. J. and Jolles, J. and Jonker, C.}, title = {{Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment}}, journal = {Journal of neurology}, year = {1999}, doi = {10.1007/s004150050387}, pmid = {10431775}, url = {https://doi.org/10.1007/s004150050387} }